Conference on Amorphous Pharmaceutical Materials

Conference on Amorphous Pharmaceutical Materials
Date Info: 14th Jun 2010 to 15th Jun 2010
Venue Info: BSG House, London, UK

Key Speakers

Ljiljana Harding, Inhalation & Devices Centre of Emphasis, Pfi zer
Franco Sartor, Principal scientist , GlaxoSmithKline
Sigrid Stokbroekx, Research Fellow, Johnson & Johnson Pharmaceutical R&D
Dr. Rolf Hilfi ker, Vice President Head of Department Solid-State Development,
Roger Parker, Senior Scientist, Food Structure and Health Programme, Institute
of Food Research
Dr. Simon Gaisford, Senior Lecturer in Pharmaceutics, The School of Pharmacy,
University of London
Mark Saunders, Owner, co-founder and Development Director, Synectix
Pharmaceutical Solutions
Robert Whittock, IP/IT Practice Group, Freshfi elds Bruckhaus Deringer LLP
Wouter Pors, Attorney, Bird & Bird
Michael Gamlen, Managing Director, Pharmaceutical Development Services
Senior Representative, Solid Form Solutions

Due to the continuous increase in the number of insoluble developmental drug
molecules and growing regulatory scrutiny over pharmaceutical solids, amorphous
pharmaceutical materials have gained importance in the last few years.
With the help of interactive discussions and leading presentations, participants
will gain a comprehensive outlook of the current market trends, discover the
latest technological developments.
During this two day event, a wide range of case studies will be presented,
covering areas of amorphous formulation to novel amorphous microparticle

Reasons to register today:

• Understand the use of isothermal calorimetry to characterise stability of
   amorphous pharmaceuticals
• Implement the latest technological developments
• Discuss the best approaches to control and stabilise amorphous drug forms
• Examine the quantifi cation of amorphous content
• Gain a clearer insight on amorphous food materials
• Seize this opportunity to network with leaders from pharma-biotech,
  and regulatory agencies
  I look forward to meeting you at the conference.
Who should attend?

VPs, Directors, Heads and Managers of:
• Stability / Stability testing
• Pre-formulation
• Solid State Chemistry
• Formulation
• Crystallisation • Drug Discovery
• Drug Delivery
• Analytical methods / development
• API Development • Validation
• Pharmacokinetics • Quality Control
• R&D
• Product Submission
• Research and Development • Materials Science
• Technical Operations
• Statistical Sciences
• Manufacturing Science
• Regulatory affairs
• Particle Engineering
• Product Design
• Business Development

To know more and to buy a copy of your report feel free to visit :


Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter: